Pharmacokinetic study of AVI 4126 [RESTEN-NG] in cerebral spinal fluid among healthy adult males following intravenous administration
Phase of Trial: Phase I
Latest Information Update: 02 Aug 2012
At a glance
- Drugs AVI 4126 (Primary)
- Indications Coronary artery restenosis
- Focus Pharmacokinetics
- Sponsors Sarepta Therapeutics
- 14 Jul 2009 Actual end date June 2009 added as reported by ClinicalTrials.gov.
- 17 Oct 2006 New trial record.